Filter posts

Value Drivers Under the Influence – How Licensing and Key Events Affect Valuation

The Tuesday plenary luncheon at the 2012 BIO CEO & Investor Conference featured a panel …

Fireside Chat with Dr. Mikael Dolsten

Day two of the BIO CEO & Investor Conference kicked off with a Fireside Chat …

Picks and Pans – The Buy-Side View for 2012

What’s the forecast for biotech in 2012? Do investors think it is a good time …

“Alz” Well That Ends Well: The Beta-Amyloid Debate in Alzheimer’s Research

Researchers and clinicians alike believe there is substantial evidence to support the hypothesis that Alzheimer’s …

Fireside Chat with Moncef Slaoui, GlaxoSmithKline

Moncel Slaoui, chairman of research and development (R&D) at GlaxoSmithKline (GSK), opened the 2012 BIO …

BIO Helps You Continuously Connect

By Rob Wright, Life Science Leader As I perused a bunch of the show agendas …

The BioGENEius Challenge: Prarthana Dalal

By Prarthana Dalal, 2011 International BioGENEius Challenge 1st Place Winner Project Title: Modeling of human …

The BioGENEius Challenge: Priyen Patel

By Priyen Patel, 2011 U.S. National BioGENEius Media Award Winner Project Title: Over-the-Counter and In …

2011 BIO International Convention Governors Highlight Reel

The 2011 BIO International Convention brought together over 15,000 leaders from industry, government and academia …

2012 BIO International Convention to Highlight Breakthroughs

2012 BIO International Convention to Highlight Breakthroughs in Healing, Fueling, and Feeding the World The …